Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Zimmerman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Developmental Cell|June 9, 2015
Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic Activation of NotchWendy R Gordon, Brandon Zimmerman, Li He, et al.
Cell|December 12, 2017
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10Tom C M Seegar, Lauren B Killingsworth, Nayanendu Saha, et al.
Nature Communications|April 19, 2017
A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signallingAlexandre Beautrait, Justine S Paradis, Brandon Zimmerman, et al.
The New England Journal of Medicine|March 15, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> VariantsOgo Egbuna, Brandon Zimmerman, George Manos, et al.
Nature Communications|January 2, 2025
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney diseaseBrandon Zimmerman, Leslie A Dakin, Anne Fortier, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Developmental Cell|June 9, 2015
Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic Activation of NotchWendy R Gordon, Brandon Zimmerman, Li He, et al.
Cell|December 12, 2017
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10Tom C M Seegar, Lauren B Killingsworth, Nayanendu Saha, et al.
Nature Communications|April 19, 2017
A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signallingAlexandre Beautrait, Justine S Paradis, Brandon Zimmerman, et al.
The New England Journal of Medicine|March 15, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> VariantsOgo Egbuna, Brandon Zimmerman, George Manos, et al.
Nature Communications|January 2, 2025
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney diseaseBrandon Zimmerman, Leslie A Dakin, Anne Fortier, et al.
Pageof 2